IQVIA HOLDINGS INC. Marketable Securities (Current)
IQVIA HOLDINGS INC. (IQV) had Marketable Securities (Current) of $156.00 million as of 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-05-05
- 2026-03-31: Marketable Securities, Current $156.00M.
- 2025-12-31: Marketable Securities, Current $161.00M.
- 2025-09-30: Marketable Securities, Current $158.00M.
- 2025-06-30: Marketable Securities, Current $149.00M.
| Period end | Marketable Securities, Current |
|---|---|
| 2026-03-31 | $156.00M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $161.00M 10-Q · filed 2026-05-05 |
| 2025-09-30 | $158.00M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $149.00M 10-Q · filed 2025-07-22 |
| 2025-03-31 | $136.00M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $141.00M 10-K · filed 2026-02-17 |
| 2024-09-30 | $140.00M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $133.00M 10-Q · filed 2024-07-22 |
| 2024-03-31 | $131.00M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $120.00M 10-K · filed 2025-02-13 |
| 2023-09-30 | $108.00M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $110.00M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $104.00M 10-Q · filed 2023-04-28 |
| 2022-12-31 | $93.00M 10-K · filed 2024-02-15 |
| 2022-09-30 | $87.00M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $90.00M 10-Q · filed 2022-07-22 |
| 2022-03-31 | $106.00M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $111.00M 10-K · filed 2023-02-15 |
| 2021-09-30 | $104.00M 10-Q · filed 2021-10-22 |
| 2021-06-30 | $104.00M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $97.00M 10-Q · filed 2021-04-23 |
| 2020-12-31 | $88.00M 10-K · filed 2022-02-16 |
| 2020-09-30 | $79.00M 10-Q · filed 2020-10-22 |
| 2020-06-30 | $73.00M 10-Q · filed 2020-07-23 |
| 2020-03-31 | $63.00M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $62.00M 10-K · filed 2021-02-12 |
| 2019-09-30 | $57.00M 10-Q · filed 2019-11-01 |
| 2019-06-30 | $56.00M 10-Q · filed 2019-07-24 |
| 2019-03-31 | $55.00M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $47.00M 10-K · filed 2020-02-18 |
| 2017-12-31 | $46.00M 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |